DMH2 is a novel and potent antagonist of bone morphogenetic protein (BMP) type I receptor with Ki values of <1, 5.4 and 43 nM for ALK6, ALK3 and ALK2, respectively. It caused a decrease in cell growth and apoptosis of H1299 non-small cell lung carcinoma cells in vitro.

纯度：≥98%

CAS：1206711-14-9